Esculetin (Coumarin)

Esculetin is a dihydroxycoumarin compound found in plants like chicory and barley that exhibits potent antioxidant activity through free radical scavenging and metal chelation. Research demonstrates its ability to enhance antioxidant enzymes like catalase and superoxide dismutase while inhibiting cancer cell growth through JNK and ERK pathway modulation.

Origin & History

Esculetin (6,7-dihydroxycoumarin) is a natural coumarin derivative primarily extracted from the twig skin and trunk bark of Fraxinus rhynchophylla Hance, a Chinese herbal medicine. It is also found enriched in plants including Sonchus grandifolius and Aesculus turbinata, characterized by two hydroxyl groups at the 6th and 7th carbon positions.

Historical & Cultural Context

Esculetin is derived from Fraxinus rhynchophylla Hance, a traditional Chinese herbal medicine. Specific historical applications and duration of traditional use are not detailed in the available research.

Health Benefits

• Antioxidant effects through free radical scavenging and metal chelation (animal studies at 100-500 mg/kg showed improved catalase and superoxide dismutase levels)
• Anti-cancer activity by downregulating JNK and ERK pathways in leukemia cells (in vitro study at 30 µg/mL)
• Anti-inflammatory action through MAPK/ERK signaling cascade inhibition (in vitro evidence only)
• Potential anti-diabetic effects mediated through antioxidant mechanisms (preliminary animal data)
• Apoptosis modulation in breast cancer cells via Ca²⁺-associated mitochondrial pathways (in vitro evidence)

How It Works

Esculetin functions as a potent antioxidant by directly scavenging free radicals and chelating metal ions that catalyze oxidative reactions. The compound enhances cellular antioxidant defense by upregulating key enzymes including catalase and superoxide dismutase. In cancer cells, esculetin demonstrates anti-proliferative effects by downregulating the c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) signaling pathways.

Scientific Research

The available research consists primarily of in vitro studies and animal models, with no human clinical trials or meta-analyses provided in the research dossier. Animal studies utilized 100-500 mg/kg doses for antioxidant effects, while cellular studies employed 5-30 µg/mL concentrations.

Clinical Summary

Current research on esculetin is primarily limited to in vitro and animal studies, with no completed human clinical trials. Animal studies using 100-500 mg/kg doses showed significant improvements in antioxidant enzyme levels including catalase and superoxide dismutase. In vitro cancer research demonstrated anti-leukemic activity at 30 µg/mL concentrations through JNK and ERK pathway inhibition. The evidence base remains preliminary and requires human clinical validation to establish therapeutic efficacy and optimal dosing.

Nutritional Profile

Esculetin (6,7-dihydroxycoumarin) is a pure bioactive coumarin compound, not a whole food ingredient, and therefore contains no macronutrients (protein, fat, carbohydrates), dietary fiber, vitamins, or minerals in any meaningful nutritional sense. As an isolated phytochemical with molecular weight of 178.14 g/mol, its profile is defined entirely by its bioactive coumarin structure. Key bioactive characteristics: belongs to the benzopyrone class of polyphenolic compounds; contains a catechol moiety (adjacent hydroxyl groups at C-6 and C-7 positions) critical for its antioxidant and metal-chelating activity. Naturally occurs in trace amounts in plant sources including chicory (Cichorium intybus), California buckeye bark, and various Euphorbia species, typically at concentrations of 0.01–0.5% dry weight depending on plant part. Bioavailability data is limited but studies indicate moderate oral absorption in rodent models; the catechol structure allows iron and copper chelation (log stability constants estimated at ~8–10 for Fe³⁺), enhancing its functional antioxidant capacity beyond simple radical scavenging. Lipophilicity (logP ~1.4) suggests moderate membrane permeability. No established dietary reference intake exists as it is not classified as an essential nutrient. Research doses in animal studies range from 100–500 mg/kg body weight; in vitro effective concentrations reported at 30–100 µg/mL. Metabolized primarily via glucuronidation and sulfation in the liver.

Preparation & Dosage

Animal studies have used 100-500 mg/kg body weight for hepatoprotective and antioxidant effects. In vitro studies employed 5-30 µg/mL concentrations. No standardized human dosage has been established due to lack of clinical trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other coumarins (umbelliferone, scopoletin), antioxidants (vitamin C, vitamin E), polyphenols

Safety & Interactions

Safety data for esculetin supplementation in humans is limited due to lack of clinical trials. As a coumarin derivative, esculetin may theoretically interact with anticoagulant medications like warfarin, though specific interactions have not been documented. Animal studies at therapeutic doses showed no acute toxicity, but long-term safety remains unknown. Pregnant and breastfeeding women should avoid esculetin supplements due to insufficient safety data.